183 related articles for article (PubMed ID: 24003724)
1. [Investigation of possible approaches to angiogenesis regulation in vitro with the help of recombinant fragments of angiogenesis inhibitors such as endostatin, tumstatin and PEDF].
Kuznetsov SL; Likhvantseva VG; Arutiunian EV; Kuz'min KA; Sel'kov SA; Sokolov DI
Vestn Ross Akad Med Nauk; 2013; (4):63-7. PubMed ID: 24003724
[TBL] [Abstract][Full Text] [Related]
2. Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization.
Sheibani N; Wang S; Darjatmoko SR; Fisk DL; Shahi PK; Pattnaik BR; Sorenson CM; Bhowmick R; Volpert OV; Albert DM; Melgar-Asensio I; Henkin J
Exp Eye Res; 2019 Nov; 188():107798. PubMed ID: 31520600
[TBL] [Abstract][Full Text] [Related]
3. [Progress on study of treatment of age-related macular degeneration by pigment epithelial-derived factor].
Hou HY; Wang YS
Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):181-5. PubMed ID: 20388353
[TBL] [Abstract][Full Text] [Related]
4. Pigment Epithelium-Derived Factor as a Possible Treatment Agent for Choroidal Neovascularization.
Xi L
Oxid Med Cell Longev; 2020; 2020():8941057. PubMed ID: 32215180
[TBL] [Abstract][Full Text] [Related]
5. The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?
Craword SE; Fitchev P; Veliceasa D; Volpert OV
Expert Opin Drug Discov; 2013 Jul; 8(7):769-92. PubMed ID: 23642051
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug.
Tan H; Mu G; Zhu W; Liu J; Wang F
Biol Pharm Bull; 2011; 34(4):545-50. PubMed ID: 21467643
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis inhibitors and the need for anti-angiogenic therapeutics.
Dass CR; Tran TM; Choong PF
J Dent Res; 2007 Oct; 86(10):927-36. PubMed ID: 17890668
[TBL] [Abstract][Full Text] [Related]
8. Negative regulators of angiogenesis: important targets for treatment of exudative AMD.
Farnoodian M; Wang S; Dietz J; Nickells RW; Sorenson CM; Sheibani N
Clin Sci (Lond); 2017 Aug; 131(15):1763-1780. PubMed ID: 28679845
[TBL] [Abstract][Full Text] [Related]
9. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
[TBL] [Abstract][Full Text] [Related]
10. The role of PEDF in tumor growth and metastasis.
Hoshina D; Abe R; Yamagishi SI; Shimizu H
Curr Mol Med; 2010 Apr; 10(3):292-5. PubMed ID: 20236054
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Topical Pigment Epithelium-Derived Factor (PEDF) with Topical Bevacizumab for Accelerating the Regression of Corneal Neovascularization in an Experimental Model of Rabbit Corneal Angiogenesis.
Mahmoudzadeh R; Heidari-Keshel S; Mehrpour M; Asadi Amoli F; Aghajanpour L; Lashay A
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1471-1477. PubMed ID: 32407187
[No Abstract] [Full Text] [Related]
12. Phosphomimetic mutants of pigment epithelium-derived factor with enhanced anti-choroidal melanoma cell activity in vitro and in vivo.
Feng Y; Bao W; Luo Y; Tian L; Chen X; Yi M; Xiong H; Huang Q
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6793-802. PubMed ID: 22952124
[TBL] [Abstract][Full Text] [Related]
13. [Pigment epithelium-derived factor and its application in retinal angiogenic diseases].
Liu H; Su GF
Zhonghua Yan Ke Za Zhi; 2007 Nov; 43(11):1043-7. PubMed ID: 18307952
[TBL] [Abstract][Full Text] [Related]
14. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.
Ohno-Matsui K; Morita I; Tombran-Tink J; Mrazek D; Onodera M; Uetama T; Hayano M; Murota SI; Mochizuki M
J Cell Physiol; 2001 Dec; 189(3):323-33. PubMed ID: 11748590
[TBL] [Abstract][Full Text] [Related]
15. Possible role of endostatin in the antiangiogenic therapy of diabetic retinopathy.
Behl T; Kotwani A
Life Sci; 2015 Aug; 135():131-7. PubMed ID: 26141993
[TBL] [Abstract][Full Text] [Related]
16. Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema.
Ünlü C; Erdogan G; Gunay BO; Kardes E; Akcay BI; Ergin A
Int Ophthalmol; 2017 Feb; 37(1):147-158. PubMed ID: 27154721
[TBL] [Abstract][Full Text] [Related]
17. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
18. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
Chan WM; Lai TY; Chan KP; Li H; Liu DT; Lam DS; Pang CP
Retina; 2008 Oct; 28(9):1308-13. PubMed ID: 18728623
[TBL] [Abstract][Full Text] [Related]
19. Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.
Tatar O; Shinoda K; Kaiserling E; Claes C; Eckardt C; Eckert T; Pertile G; Boeyden V; Scharioth GB; Yoeruek E; Szurman P; Bartz-Schmidt KU; ; Grisanti S
Br J Ophthalmol; 2009 Feb; 93(2):159-65. PubMed ID: 18838410
[TBL] [Abstract][Full Text] [Related]
20. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.
Ek ET; Dass CR; Choong PF
Trends Mol Med; 2006 Oct; 12(10):497-502. PubMed ID: 16962374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
